Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Askoxylakis, Vasileios ^a,b   Millonig, Gunda ^a   Wirkner, Ute ^a,b   Schwager, Christian ^a,b   Rana, Shoaib ^a   Altmann, Annette ^b   Haberkorn, Uwe ^a,b   Debus, Jürgen ^a   Mueller, Sebastian ^a   Huber, Peter E ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; CATALASE; ENZYME; GLUCOSE OXIDASE; PROTEIN LYSINE 6 OXIDASE; DIAGNOSTIC AGENT;

ACIDIFICATION; ARTICLE; CANCER CELL; CELL HYPOXIA; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ASSAY; ENZYME KINETICS; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PHOTON THERAPY; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; CULTURE TECHNIQUE; DNA MICROARRAY; GENE EXPRESSION PROFILING; HEAD AND NECK TUMOR; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CATALASE; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE OXIDASE; HEAD AND NECK NEOPLASMS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79953765456     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-35     Document Type: Article

References (42)

1. Milani M, Harris AL. Targeting tumour hypoxia in breast cancer. Eur J Cancer 2008, 44:2766-2773. 10.1016/j.ejca.2008.09.025, 18990559.
2. Brown JM. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today 2000, 6:157-162. 10.1016/S1357-4310(00)01677-4, 10740254.
3. Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. Lysyl oxidase is essential for hypoxia induced metastasis. Nature 2006, 440:1222-1226. 10.1038/nature04695, 16642001.
4. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3:347-361. 10.1016/S1535-6108(03)00085-0, 12726861.
5. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002, 62:3387-3394.
6. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953, 26:638-648. 10.1259/0007-1285-26-312-638, 13106296.
7. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485-490. 10.1038/28867, 9697772.
8. Allen CB, Schneider KB, White CW. Limitations to oxygen diffusion and equilibration in in vitro cell exposure systems in hyperoxia and hypoxia. Am J Physiol Lung Cell Mol Physiol 2001, 281:1021-1027.
9. Baumann RP, Penketh PG, Seow HA, Shyam K, Sartorelli AC. Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells. Radiat Res 2008, 170:651-660. 10.1667/RR1431.1, 2667281, 18959466.
10. Millonig G, Hegedüsch S, Becker L, Seitz HK, Schuppan D, Mueller S. Hypoxia-inducible factor 1 alpha under rapid enzymatic hypoxia: cells sense decrements of oxygen but not hypoxia per se. Free Radic Biol Med 2009, 46:182-191. 10.1016/j.freeradbiomed.2008.09.043, 19007879.
11. Troost EG, Schinagl DA, Bussink J, Boerman OC, van der Kogel AJ, Oyen WJ, Kaanders JH. Innovations in radiotherapy planning of head and neck cancers: role of PET. J Nucl Med 2010, 51:66-76. 10.2967/jnumed.108.061499, 20009000.
12. Ninck S, Reisser C, Dyckhoff G, Helmke B, Bauer H, Herold-Mende C. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 2003, 106:34-44. 10.1002/ijc.11188, 12794754.
13. Haberkorn U, Altmann A, Kamencic H, Morr I, Traut U, Henze M, Jiang S, Metz J, Kinscherf R. Glucose transport and apoptosis after gene therapy with HSV thymidine kinase. Eur J Nucl Med 2001, 28:1690-1696. 10.1007/s002590100644, 11702112.
14. Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, Weber KJ, Huber PE. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells. Int J Radiat Oncol Biol Phys 2004, 60:1220-1232. 10.1016/j.ijrobp.2004.07.689, 15519795.
15. Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ. An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 2009, 37:4587-4602. 10.1093/nar/gkp425, 2724271, 19491311.
16. Demir R, Naschberger L, Demir I, Melling N, Dimmler A, Papadopoulus T, Sturzl M, Klein P, Hohenberger W. Hypoxia generates a more invasive phenotype of tumour cells: an in vivo experimental setup based on the chorioallantoic membrane. Pathol Oncol Res 2009, 15:417-422. 10.1007/s12253-008-9140-y, 19082873.
17. Baumann RP, Penketh PG, Ishiguro K, Shyam K, Zhu YL, Sartorelli AC. Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance. Biochem Pharmacol 2010, 79:1553-1561. 10.1016/j.bcp.2009.12.004, 2885764, 20005211.
18. Zitta K, Meybohm P, Bein B, Rodde C, Steinfath M, Scholz J, Albrecht M. Hypoxia-induced cell damage is reduced by mild hypothermia and postconditioning with catalase in-vitro: application of an enzyme based oxygen deficiency system. Eur J Pharmacol 2010, 628:11-18. 10.1016/j.ejphar.2009.11.023, 19917279.
19. Zitta K, Meybohm P, Bein B, Ohnesorge H, Steinfath M, Scholz J, Albrecht M. Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model. Eur J Pharmacol 2010, 645:39-46. 10.1016/j.ejphar.2010.07.017, 20655305.
20. Owegi HO, Egot-Lemaire S, Waite LR, Waite GN. Macrophage activity in response to steady-state oxygen and hydrogen peroxide concentration- biomed 2010. Biomed Sci Instrum 2010, 46:57-62.
21. Silva P, Homer JJ, Slevin NJ, Musgrove BT, Sloan P, Price P, West CM. Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review. Clin Otolaryngol 2007, 32:337-345. 10.1111/j.1749-4486.2007.01544.x, 17883552.
22. Sørensen BS, Horsman MR, Vorum H, Honoré B, Overgaard J, Alsner J. Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics. Radiother Oncol 2009, 92:443-449.
23. Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, Peters LJ, . Trans-Tasman Radiation Oncology Group Study 98.02 Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006, 24:2098-2104. 10.1200/JCO.2005.05.2878, 16648512, Trans-Tasman Radiation Oncology Group Study 98.02.
24. De Schutter H, Landuyt W, Verbeken E, Goethals L, Hermans R, Nuyts S. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy. BMC Cancer 2005, 5:42. 10.1186/1471-2407-5-42, 1097720, 15847702.
25. Le QT, Harris J, Magliocco AM, Kong CS, Diaz R, Shin B, Cao H, Trotti A, Erler JT, Chung CH, Dicker A, Pajak TF, Giaccia AJ, Ang KK. Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03. J Clin Oncol 2009, 27:4281-4286. 10.1200/JCO.2008.20.6003, 2744270, 19667273.
26. Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010, 20:51-56. 10.1016/j.gde.2009.10.009, 2822127, 19942427.
27. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998, 12:149-162. 10.1101/gad.12.2.149, 316445, 9436976.
28. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033. 10.1126/science.1160809, 2849637, 19460998.
29. Pfeiffer T, Schuster S, Bonhoeffer S. Cooperation and competition in the evolution of ATP-producing pathways. Science 2001, 292:504-507. 10.1126/science.1058079, 11283355.
30. Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer 2009, 9:691-700. 10.1038/nrc2715, 19759539.
31. Maschauer S, Prante O, Hoffmann M, Deichen JT, Kuwert T. Characterization of 18F-FDG uptake in human endothelial cells in vitro. J Nucl Med 2004, 45:455-460.
32. Gaposchkin CG, Garcia-Diaz JF. Modulation of cultured brain, adrenal, and aortic endothelial cell glucose transport. Biochim Biophys Acta 1996, 1285:255-266. 10.1016/S0005-2736(96)00172-1, 8972710.
33. Regina A, Roux F, Revest PA. Glucose transport in immortalized rat brain capillary endothelial cells in vitro: transport activity and GLUT1 expression. Biochim Biophys Acta 1997, 1335:135-143.
34. Mueller S, Millonig G, Waite GN. The GOX/CAT system: a novel enzymatic method to independently control hydrogen peroxide and hypoxia in cell culture. Adv Med Sci 2009, 54:121-135. 10.2478/v10039-009-0042-3, 20022860.
35. Freyer JP, Sutherland RM. A reduction in the in situ rates of oxygen and glucose consumption of cells in EMT6/Ro spheroids during growth. J Cell Physiol 1985, 124:516-524. 10.1002/jcp.1041240323, 4044662.
36. Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003, 67:3-15. 10.1016/S0167-8140(03)00011-2, 12758235.
37. Jubb AM, Pham TQ, Hanby AM, Frantz GD, Peale FV, Wu TD, Koeppen HW, Hillan KJ. Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours. J Clin Pathol 2004, 57:504-512. 10.1136/jcp.2003.012963, 1770303, 15113858.
38. Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, Nath KA. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 2001, 60:2181-2191. 10.1046/j.1523-1755.2001.00046.x, 11737592.
39. Griffiths JR. Are cancer cells acidic?. Br J Cancer 1991, 64:425-427. 10.1038/bjc.1991.326, 1977628, 1911181.
40. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009, 69:2260-2268. 10.1158/0008-5472.CAN-07-5575, 2834485, 19276390.
41. Ferreira LM. Cancer metabolism: the Warburg effect today. Exp Mol Pathol 2010, 89:372-380. 10.1016/j.yexmp.2010.08.006, 20804748.
42. Andriopoulos B, Hegedüsch S, Mangin J, Riedel HD, Hebling U, Wang J, Pantopoulos K, Mueller S. Sustained hydrogen peroxide induces iron uptake by transferrin receptor-1 independent of the iron regulatory protein/iron responsive element network. J Biol Chem 2007, 282:20301-20308. 10.1074/jbc.M702463200, 17517884.